Peptide Deformylase (Def) (AA 51-199) antibody
Quick Overview for Peptide Deformylase (Def) (AA 51-199) antibody (ABIN7875509)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 51-199
-
Purpose
- Peptide deformylase Antibody / PDF
-
Purification
- Antigen affinity chromatography
-
Immunogen
- An E.coli-derived human recombinant protein (amino acids H51-Q199) was used as the immunogen for the Peptide deformylase antibody.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal dilution of the Peptide deformylase antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- After reconstitution, the Peptide deformylase antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- Peptide Deformylase (Def)
-
Alternative Name
- Peptide deformylase
-
Background
- Protein synthesis proceeds after formylation of methionine by methionyl-tRNA formyl transferase (FMT) and transfer of the charged initiator f-met tRNA to the ribosome. In eubacteria and eukaryotic organelles the product of this gene, Peptide deformylase (PDF), removes the formyl group from the initiating methionine of nascent peptides. In eubacteria, deformylation of nascent peptides is required for subsequent cleavage of initiating methionines by methionine aminopeptidase. The discovery that a natural inhibitor of PDF, actinonin, acts as an antimicrobial agent in some bacteria has spurred intensive research into the design of bacterial-specific PDF inhibitors. In human cells, only mitochondrial proteins have N-formylation of initiating methionines. Protein inhibitors of PDF or siRNAs of PDF block the growth of cancer cell lines but have no effect on normal cell growth. In humans, PDF function may therefore be restricted to rapidly growing cells.
-
UniProt
- Q9HBH1
Target
-